| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036644837 |
| P356 | DOI | 10.1038/PCAN.2012.22 |
| P698 | PubMed publication ID | 22733158 |
| P5875 | ResearchGate publication ID | 228066404 |
| P50 | author | Dennis R. Taaffe | Q37835012 |
| P2093 | author name string | D A Galvão | |
| N Spry | |||
| R U Newton | |||
| K A Bolam | |||
| P2860 | cites work | Functional results after treatment of hip fracture: a multicentre, prospective study in 215 patients | Q73981086 |
| Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study | Q74192555 | ||
| Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer | Q74260413 | ||
| Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer | Q74591878 | ||
| A school-based exercise intervention augments bone mineral accrual in early pubertal girls | Q74615408 | ||
| Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise | Q77650540 | ||
| Androgens and bone | Q79811504 | ||
| Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer | Q80027418 | ||
| Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma | Q81100244 | ||
| Risk of fracture after androgen deprivation for prostate cancer | Q81264327 | ||
| Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer | Q81272515 | ||
| Fracture risk in patients with prostate cancer on androgen deprivation therapy | Q81407226 | ||
| Effects of walking-only interventions on bone mineral density at various skeletal sites: a meta-analysis | Q82136296 | ||
| Optimum frequency of exercise for bone health: randomised controlled trial of a high-impact unilateral intervention | Q82218041 | ||
| Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation | Q82286516 | ||
| Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression | Q83116563 | ||
| American College of Sports Medicine position stand. Exercise and physical activity for older adults | Q84043243 | ||
| Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial | Q84965106 | ||
| Exercise and bone mass in adults | Q37488186 | ||
| Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure | Q37504664 | ||
| Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer | Q37630362 | ||
| The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. | Q37678989 | ||
| American College of Sports Medicine roundtable on exercise guidelines for cancer survivors | Q37766069 | ||
| Strength training as a countermeasure to aging muscle and chronic disease. | Q37855784 | ||
| High intensity resistance training: effects on bone in older men and women | Q39119618 | ||
| Using functional loading to influence bone mass and architecture: objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process in bone | Q41039780 | ||
| Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma | Q41347991 | ||
| Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy | Q42060244 | ||
| Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy | Q42873433 | ||
| Regular physical exercise and bone mineral density: a four-year controlled randomized trial in middle-aged men. The DNASCO study | Q43667171 | ||
| Osteogenic index and changes in bone markers during a jump training program: a pilot study | Q44235353 | ||
| Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss | Q44355814 | ||
| Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer | Q44836371 | ||
| Changes in bone mineral density differ between gonadotrophin-releasing hormone analogue- and surgically castrated men with prostate cancer--a prospective, controlled, parallel-group study | Q44942089 | ||
| Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition | Q44958689 | ||
| Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy | Q44973516 | ||
| Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression | Q45185323 | ||
| Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy | Q46212689 | ||
| Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial | Q46287984 | ||
| Differential effects of swimming versus weight-bearing activity on bone mineral status of eumenorrheic athletes | Q46562081 | ||
| Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. | Q46705671 | ||
| Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer | Q46749977 | ||
| Evidence-based guidelines for the secondary prevention of falls in older adults | Q47614280 | ||
| Effect of low-repetition jump training on bone mineral density in young women. | Q51833700 | ||
| Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer | Q53932137 | ||
| Resistance exercise and bone turnover in elderly men and women. | Q53983215 | ||
| Resistance training over 2 years increases bone mass in calcium-replete postmenopausal women. | Q54023947 | ||
| Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men. | Q54241636 | ||
| Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. | Q55192988 | ||
| Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden | Q56109689 | ||
| Association of Long-Distance Corridor Walk Performance With Mortality, Cardiovascular Disease, Mobility Limitation, and Disability | Q57392258 | ||
| Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients | Q57541062 | ||
| Androgens and Bone | Q57606357 | ||
| Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men | Q58311371 | ||
| Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial | Q61933712 | ||
| Frequent walking, but not total physical activity, is associated with increased fracture incidence: A 5-year follow-up of an Australian population-based prospective study (AusDiab) | Q61933747 | ||
| Muscle strength as a predictor of bone mineral density in young women | Q68879971 | ||
| Determinants of bone mineral density in older men | Q70981494 | ||
| Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures | Q71778172 | ||
| Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial | Q72880870 | ||
| Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31 | Q73132167 | ||
| Fracture risk following bilateral orchiectomy | Q73247169 | ||
| Progressive osteoporosis during androgen deprivation therapy for prostate cancer | Q73288056 | ||
| Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children | Q73407554 | ||
| Metabolic complications of androgen deprivation therapy for prostate cancer | Q24616159 | ||
| Health behaviors of cancer survivors: data from an Australian population-based survey. | Q31119150 | ||
| Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial | Q31846841 | ||
| Muscle training for bone strength | Q33243553 | ||
| A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer | Q33475929 | ||
| Bone health and prostate cancer | Q33977536 | ||
| Osteoporosis due to androgen deprivation therapy in men with prostate cancer | Q34335652 | ||
| American College of Sports Medicine Position Stand: physical activity and bone health. | Q34363250 | ||
| High-impact exercise promotes bone gain in well-trained female athletes | Q34417111 | ||
| Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. | Q34525190 | ||
| Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent | Q34734861 | ||
| Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer | Q35016890 | ||
| Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial | Q35072496 | ||
| Aging bone and osteoporosis: strategies for preventing fractures in the elderly | Q35558780 | ||
| Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies | Q35675197 | ||
| Intermittent androgen deprivation therapy for prostate cancer | Q35787980 | ||
| Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. | Q35808379 | ||
| Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma | Q36059488 | ||
| Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors | Q36247308 | ||
| Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer | Q36300841 | ||
| Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study | Q36465030 | ||
| Androgen deprivation in veterans with prostate cancer: implications for skeletal health | Q36667394 | ||
| Bone mineral density in weight lifters | Q36781528 | ||
| Emerging therapies to prevent skeletal morbidity in men with prostate cancer | Q36910469 | ||
| Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates | Q36965659 | ||
| Meta-analysis of walking for preservation of bone mineral density in postmenopausal women | Q37207748 | ||
| A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes | Q37316221 | ||
| Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer | Q37462502 | ||
| P433 | issue | 4 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 329-338 | |
| P577 | publication date | 2012-06-26 | |
| P1433 | published in | Prostate Cancer and Prostatic Diseases | Q2108326 |
| P1476 | title | AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure | |
| P478 | volume | 15 |
| Q42281198 | Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial |
| Q51732172 | Impact of physical exercise in cancer survivors during and after antineoplastic treatments. |
| Q91987362 | Sport Medicine in the Prevention and Management of Cancer |
Search more.